Prof. Dr. Thomas Kiefhaber 1993 - 2007 | Professor of Biophysical Chemistry Thomas Kiefhaber studied and graduated with a doctorate at the Universities of Regensburg and Bayreuth in the field of biophysics. From 1991 until…

Prof. Dr. Joachim Seelig, Emeritus 1972 - 2012 | Professor of Structural Biology Since 1972 Joachim Seelig (*1942, † 2024) carried out research, first, as Assistant Professor and since 1982 as Full Professor of Structural…

A challenging journey… Yuping Li, new Professor of Infection and Immunity at the Biozentrum, is a rather quiet person. The pressure and stress she has experienced in her life are not immediately apparent. Particularly, being…

Media & Lab Ware Preparation The Media & Lab Ware Preparation (MLP) team at the Biozentrum is responsible for a wide variety of tasks. One of the main functions is to appropriately treat the used lab and experimental…

2023 This year, we talked to three of our dedicated female PIs at the Biozentrum about their research and ideas of how to achieve gender equality in science. Silvia Arber, Professor of Neurobiology “Follow your dreams, be…

CV of Prof. Dr. Ben Engel ORCID 0000-0002-0941-4387 Google Scholar Google Scholar Nationality : USA Positions: Since 2022 Assistant Professor, Biozentrum, University of Basel, Switzerland 2020 – 2022 Junior Fellow ,…

CV of Prof. Dr. Maria Hondele ORCID 0000-0002-2733-2561 Google Scholar Google Scholar Nationality: German Positions: Since 2020 Tenure-track Assistant Professor at the Biozentrum of the University of Basel, Switzerland 2014…

Prof. Dr. Edward De Robertis 1980 – 1985 | Professor of Cell Biology Edward De Robertis, was born in Boston, Massachusetts, studied Medicine in Uruguay and completed his PhD in Chemistry at the Leloir Institute in Buenos…

With its Starting Grant, the ERC supports outstanding young researchers who lay the foundation for an independent research program with their innovative projects. One of this year’s awardees is physicist Prof. David…

T3 Pharmaceuticals (“T3 Pharma”) was founded in 2015 as a spin-off of the Biozentrum of the University of Basel. The company focuses on bacterial therapies for the treatment of solid tumors. The Basel-based biotech company’s…